Esterase-triggered fluorescence of fluorogenic oligonucleotides

被引:13
作者
Laurent, A
Debart, F
Lamb, N
Rayner, B
机构
[1] UNIV MONTPELLIER 2,CHIM BIOORGAN LAB,CNRS,UMR 5625,F-34095 MONTPELLIER 5,FRANCE
[2] CNRS,CTR RECH BIOCHIM MACROMOL,UNITE BIOL CELLULAIRE,F-34033 MONTPELLIER,FRANCE
关键词
D O I
10.1021/bc970168i
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In the prooligonucleotide approach, a step of activation by cellular esterases is necessary for the removal of internucleoside phosphate masking groups and subsequent intracellular delivery of active antisense oligonucleotides. The efficacy of this approach implies that prooligonucleotides, once they are taken up by cells, are demasked by esterases during their course to their nucleic acid targets. In this regard, a method for labeling oligomers with esterase-activable fluorogenic tag was designed. The two phenolic functions of carboxyfluorescein mere protected by pivaloyl groups, yielding a nonfluorescent lactone which was further activated as a N-hydroxysuccinimide ester. Two nuclease-resistant phosphorothioate 18-mer and methylphosphonate 19-mer oligodeoxynucleosides were attached to this biprotected fluorescein derivative via an amino linker at the 5'-end of the oligomers. The two conjugates were assayed for their carboxyesterase substrate ability in different biological media, In the presence of purified esterases or when incubated in serum or cell extracts, both oligonucleotide conjugates became fluorescent. In addition, the phosphorothioate oligoconjugate was microinjected into the cytoplasm of human fibroblasts, and a fast cytoplasmic release of fluorescence was observed with a rapid translocation of the fluorescent oligomer into the nucleus.
引用
收藏
页码:856 / 861
页数:6
相关论文
共 23 条
[1]   PREPARATION OF OLIGONUCLEOTIDE-DEXAMETHASONE CONJUGATES [J].
ACEDO, M ;
TARRASON, G ;
PIULATS, J ;
MANN, M ;
WILM, M ;
ERITJA, R .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (15) :1577-1580
[2]  
Agrawal Sudhir, 1994, V26, P93
[3]   THE PROOLIGONUCLEOTIDE APPROACH .2. SYNTHESIS AND STABILITY STUDIES OF CHIMERIC OLIGONUCLEOTIDE MODELS [J].
BARBER, I ;
TOSQUELLAS, G ;
MORVAN, F ;
RAYNER, B ;
IMBACH, JL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (14) :1441-1444
[4]   THE PROOLIGONUCLEOTIDE APPROACH .1. ESTERASE-MEDIATED REVERSIBILITY OF DITHYMIDINE-S-ALKYL-PHOSPHOROTHIOLATES TO DITHYMIDINE PHOSPHOROTHIOATES [J].
BARBER, I ;
RAYNER, B ;
IMBACH, JL .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (06) :563-568
[5]  
CHIN D J, 1990, New Biologist, V2, P1091
[6]   INTRACELLULAR DISPOSITION AND METABOLISM OF FLUORESCENTLY-LABELED UNMODIFIED AND MODIFIED OLIGONUCLEOTIDES MICROINJECTED INTO MAMMALIAN-CELLS [J].
FISHER, TL ;
TERHORST, T ;
CAO, XD ;
WAGNER, RW .
NUCLEIC ACIDS RESEARCH, 1993, 21 (16) :3857-3865
[7]   Synthesis and properties of an oligonucleotide modified with an acridine derivative at the artificial abasic site [J].
Fukui, K ;
Morimoto, M ;
Segawa, H ;
Tanaka, K ;
Shimidzu, T .
BIOCONJUGATE CHEMISTRY, 1996, 7 (03) :349-355
[8]  
GILES RV, 1993, ANTI-CANCER DRUG DES, V8, P33
[9]  
GIRARD F, 1995, J CELL SCI, V108, P2599
[10]  
Hogrefe R I, 1993, Methods Mol Biol, V20, P143